Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09CVV
|
||||
| Former ID |
DNC013482
|
||||
| Drug Name |
NORSTEPHALAGINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551362] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H17NO3
|
||||
| Canonical SMILES |
COC1=C2CCNC3C2=C(C4=CC=CC=C4C3)C5=C1OCO5
|
||||
| InChI |
1S/C18H17NO3/c1-20-16-12-6-7-19-13-8-10-4-2-3-5-11(10)15(14(12)13)17-18(16)22-9-21-17/h2-5,13,19H,6-9H2,1H3/t13-/m1/s1
|
||||
| InChIKey |
TYZKUSBTFHNPMV-CYBMUJFWSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Dopamine D1 receptor | Target Info | Inhibitor | [528616] | |
| Sodium-dependent dopamine transporter | Target Info | Inhibitor | [551362] | ||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| WikiPathways | Hypothetical Network for Drug Addiction | ||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Genes and (Common) Pathways Underlying Drug Addiction | |||||
| GPCR ligand binding | |||||
| GPCR downstream signalingWP727:Monoamine Transport | |||||
| NRF2 pathway | |||||
| Dopaminergic Neurogenesis | |||||
| Parkinsons Disease Pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| Neurotransmitter Clearance In The Synaptic Cleft | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.